MedicarePartD.guide

A non-government resource built from CMS public data

CGRP migraine drugs on Blue MedicareRx Value Plus (S2893-001)

Aimovig, Ajovy, Emgality, Nurtec, Ubrelvy and Qulipta, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Connecticut + 3 more
Premium
$20.70/month
Deductible
$615.00, doesn't apply to tier 1
Change plan

5 of 7 CGRP migraine drugs are covered on this plan. All 5 require prior authorization.

2 aren't on the formulary (Ajovy and Zavzpret).

  • Aimovig
    erenumab
    Covered · prior auth
    $127.09
    Tier 3
  • Emgality
    galcanezumab
    Covered · prior auth
    from $247.96
    Tier 3
  • Nurtec ODT
    rimegepant
    Covered · prior auth
    $348.95
    Tier 3
  • Ubrelvy
    ubrogepant
    Covered · prior auth
    from $295.74
    Tier 3
  • Qulipta
    atogepant
    Covered · prior auth
    from $195.46
    Tier 3
Not on the formulary
Ajovy, Zavzpret

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list